Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status
- 1 December 2004
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 31, 27-31
- https://doi.org/10.1053/j.seminoncol.2004.10.006
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancerBritish Journal of Cancer, 2003
- Single-agent chemotherapy for non-small cell lung cancerLung Cancer, 2003
- Management of patients with non-small cell lung cancer and poor performance status.Current Treatment Options in Oncology, 2003
- Does chemotherapy have a role as palliative therapy for unfit or elderly patients with non-small-cell lung cancer?Lung Cancer, 2002
- Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 casesAnnals of Oncology, 2002
- Is There a Preferred Combination Chemotherapy Regimen for Metastastic Non-Small Cell Lung Cancer?The Oncologist, 2002
- Outcome of patients with a performance status of 2 in Eastern Cooperative Oncology Group Study E1594Cancer, 2001